Test was failing because of change of login page design. Element which
contained title headers was moved from header title to another element.
Was not fixed upon initial commit (ca15db) because test's only turned on
by profile.
* KEYCLOAK-6849 - LinkedIn social login provider updated to new LinkedIn
OAuth2 endpoint
* KEYCLOAK-6849 - LinkedIn social login provider test updated
* KEYCLOAK-6849 - LinkedIn social login provider test updated to
conditionally handle consent page when shown only
* Simplify the LinkedIn app authorization
This reverts commit c12359e7a13d9ff231fe2e25cddba66ad679a9cd.
Access Control is not an 'a' tag, but rather 'span'
Also two tests do not behave correctly with a same
Before annotated initialization, so reduce number
of tests to one, which calls the other one
remove built directory
update snapshot version references
refactor out core library to remove duplication
adapter for spring boot 2
remove built directory
update snapshot version references
Revert "merge from upstream"
This reverts commit 88c39a2f23b8f2d4b25360e2b46e683d11b4972b, reversing
changes made to f0811145ceeb8ec609ed66b06067f797e288aa89.
setting correct versions
updating to latest keycloak
arquillian test app for spring boot2
update to 2.0.0.RELEASE
added Rest Customizer
* KEYCLOAK-6262 Incorporate new visual design from PatternFly
Update the username or email
Fix narrow/wide in template.ftl
minor style update
Add the Realm HTML name and image
Config OTP and Update Password
Not display the locale selector if there is less than 1 locale.
Fix margins/paddings on config otp screens
Fix title
Upgraded to PatternFly 3.41.6
Added RCUE and updated RH-SSO login theme
Refine the RCUE padding issue
Fix tests
Fix Keycloak background
Fix
* fix the overflowing issue
* Fix Console UI Tests to reflect the new login page
* Fix the different style of the IdP buttons
Fix the IE placeholder issue - add label
* Removed placeholder on login and reset pass. Fixed Keycloak background on wide screens.
* fixed the stackoverflow issues
fixed the width in the tablets
